The tweet was deleted by the author.
But we saved everything 🙂.
CME Group has launched 24/7 trading for its 1-Ounce Gold (1OZ) futures. This marks the first weekend of uninterrupted trading for the product.
Market participants are now experiencing continuous price discovery and liquidity. CME Group announced the news via its official Twitter account.
The current price of CME Group ($256.22) is trading well above its MA-20 ($239.66), indicating short-term bullish momentum, but it is just beneath MA-50 ($256.52), suggesting medium-term resistance, and still considerably below MA-200 ($278.68), which keeps the long-term trend under pressure from sellers. The Ichimoku Kijun level on D1 is $237.95, which sits below the current price, thereby serving as immediate support. Near-term support is found at the Ichimoku Kijun ($237.95), followed by key support at MA-20 ($239.66). For resistance, the immediate level is MA-50 ($256.52), while key resistance is further up at MA-100 ($277.56).
Momentum indicators on D1 are mixed. ADX signals ongoing buying pressure, but MACD is neutral, indicating waning upward momentum. RSI reads 57.88, in bullish territory, yet Stoch RSI and CCI both flag overbought conditions, suggesting possible short-term exhaustion. BBP shows buyers dominate intraday momentum. The Awesome Oscillator is neutral and does not add directional conviction. Over the past week, CME has risen $0.91 (0.36%) to $256.22 from a previous weekly close of $255.31. The price is currently at the very top of the weekly range, as it tests resistance after a strong recovery from the early week low. Weekly volatility stands at 8.60%. There is a notable divergence between rising weekly price action and multiple overbought signals on D1 oscillators, which raises caution for near-term upside.
Looking ahead to the next week, CME is expected to trade in a range of $243.70 to $258.00, reflecting typical weekly volatility and keeping the price anchored between the 52-week low ($218.31) and high ($329.16). Using the prescribed probability model, the likelihood of price increases is at a very low probability (less than 20%), making a decline more likely. The baseline scenario sees CME fluctuating sideways in this defined corridor as both buyers and sellers test short-term extremes. A bullish breakout would require a sustained move above the $256.50–$258.00 MA-50/near-resistance zone, while a bearish scenario would be triggered if the price slips below the $239.50–$243.70 support band, opening the door to a deeper pullback toward the year’s lower bounds.
Previously it was reported that CME Group reintroduced single-stock futures to the U.S. market, aiming to attract both retail and institutional investors with expanded access and new contract sizes. This development adds another layer to CME's evolving product strategy, and going forward, market participants should monitor how liquidity and adoption in these futures impact CME's competitive position in the derivatives space.